Lantheus Holdings Inc.

09/15/2024 | Press release | Distributed by Public on 09/15/2024 07:15

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA Positive Metastatic Castration Resistant Prostate Cancer During ESMO Congress 2024